Prothena Corp. Plc (PRTA)
8.275
-0.08
(-1.02%)
USD |
NASDAQ |
Oct 05, 16:00
8.275
0.00 (0.00%)
After-Hours: 20:00
Prothena Enterprise Value : 151.38M for Oct. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 151.38M |
| October 01, 2026 | 160.69M |
| September 30, 2026 | 152.42M |
| September 29, 2026 | 173.11M |
| September 28, 2026 | 170.01M |
| September 25, 2026 | 147.76M |
| September 24, 2026 | 149.31M |
| September 23, 2026 | 167.94M |
| September 22, 2026 | 183.98M |
| September 21, 2026 | 159.14M |
| September 18, 2026 | 162.76M |
| September 17, 2026 | 156.55M |
| September 16, 2026 | 145.17M |
| September 15, 2026 | 149.83M |
| September 14, 2026 | 177.25M |
| September 11, 2026 | 180.87M |
| September 10, 2026 | 185.53M |
| September 09, 2026 | 200.02M |
| September 08, 2026 | 212.44M |
| September 04, 2026 | 226.93M |
| September 03, 2026 | 215.54M |
| September 02, 2026 | 219.94M |
| September 01, 2026 | 216.06M |
| August 31, 2026 | 202.61M |
| August 28, 2026 | 201.57M |
| Date | Value |
|---|---|
| August 27, 2026 | 189.15M |
| August 26, 2026 | 197.43M |
| August 25, 2026 | 206.23M |
| August 24, 2026 | 204.68M |
| August 21, 2026 | 207.78M |
| August 20, 2026 | 186.05M |
| August 19, 2026 | 199.50M |
| August 18, 2026 | 169.49M |
| August 17, 2026 | 178.29M |
| August 14, 2026 | 177.25M |
| August 13, 2026 | 188.64M |
| August 12, 2026 | 197.95M |
| August 11, 2026 | 195.88M |
| August 10, 2026 | 190.71M |
| August 07, 2026 | 172.08M |
| August 06, 2026 | 162.76M |
| August 05, 2026 | 158.11M |
| August 04, 2026 | 158.11M |
| August 03, 2026 | 149.83M |
| July 31, 2026 | 138.96M |
| July 30, 2026 | 153.97M |
| July 29, 2026 | 161.73M |
| July 28, 2026 | 161.73M |
| July 27, 2026 | 168.97M |
| July 24, 2026 | 171.56M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Alkermes Plc | 7.911B |
| Amarin Corp. Plc | -50.22M |
| Agenus, Inc. | 620.93M |
| Amgen, Inc. | 261.20B |
| BioCryst Pharmaceuticals, Inc. | 2.569B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -18.58M |
| Revenue (Quarterly) | 1.01M |
| Total Expenses (Quarterly) | 19.59M |
| EPS Diluted (Quarterly) | -0.3564 |
| Gross Profit Margin (Quarterly) | 9.50% |
| Profit Margin (Quarterly) | -1.84K% |
| Earnings Yield | -10.05% |
| Normalized Earnings Yield | -10.72 |